Previous 10 | Next 10 |
New York, NY, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it re...
Reports on Business combination agreement progress ALLEN, TX / ACCESSWIRE / August 8, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) ( https://enzolytics.com/ ). Virogentics, Inc. ("VIRO") a wholly owned subsidiary of Enzolytics, Inc. (the "Company" or "ENZC"), a drug development biotech company, ...
New York, NY, July 28, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it rec...
2023-06-30 14:52:07 ET SPAC Sagaliam Acquisition Corp. ( NASDAQ: SAGA ) said it has agreed to raise the combined purchase price of Enzolytics' ( OTCPK:ENZC ) Biogenysis and Virogentics units to $450M from $250M. Sagaliam and Enzolytics said that terms of the non-binding term...
NEW YORK, NY / ACCESSWIRE / June 30, 2023 / Sagaliam Acquisition Corp. (NASDAQ:"SAGAU", "SAGA", "SAGAR") (" we ", " us ", " our ", or the " Compan y") announced today that it has amended the executed non-binding term sheet for the purchase of Biogenysis, Inc. ("BGEN") and Virogentics Inc. ("VIRO...
2023-06-05 07:03:03 ET Sagaliam Acquisition ( NASDAQ: SAGA ) has received a notification letter from Nasdaq confirming the company has regained compliance with Nasdaq's listing rule. Nasdaq had earlier notified the company is not in compliance, as...
New York, NY, June 02, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it rec...
New York, NY, May 11, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that Thomas ...
New York, NY, April 21, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it re...
New York, NY, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, “SAGAR”) (“ we ”, “ us ”, “ our ”, or the “ Compan y”) announced today that it was...
News, Short Squeeze, Breakout and More Instantly...
Sagaliam Acquisition Corp. Company Name:
SAGA Stock Symbol:
NASDAQ Market:
BAYTOWN, TX / ACCESSWIRE / May 1, 2024 / Sagaliam Acquisition Corp ("SAGA", the "Company") (NASDAQ:SAGA) announced today that Virogentics, Inc., a wholly owned subsidiary of SAGA ("VIRO"), and the Bulgarian product development team, headed by Dr. Lachezar Ivanov and Harry Zhabilov, CSO, have dev...
NEW YORK, NY / ACCESSWIRE / April 26, 2024 / Sagaliam Acquisition Corp. ("SAGAU", "SAGA", SAGAR") (the " Company ") announced that Sagaliam entered into a Novation Agreement with Enzolytics, Inc. (OTC PINK:ENZC), Biogenysis, Inc. (BGEN), and Virogentics, Inc. (VIRO) (together the "Parties"). ...
New York, NY, March 07, 2024 (GLOBE NEWSWIRE) -- Sagaliam Acquisition Corp. (NASDAQ: “SAGAU”, “SAGA”, SAGAR”) (the “ Company ”) received a Nasdaq Hearing Withdrawal letter (“ Notice ”) from the Listing Qualifications staff of ...